Stem cell mobilization in healthy donors: Current status

Infusionstherapie und Transfusionsmedizin

Volumn 26, Issue 2, 1999, Pages 92-95

  Dreger, P ^a   Schmitz, N ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b NONE

Author keywords

Allogeneic; CSF; PBSC

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3;

CELL PROLIFERATION; CELL STIMULATION; GROWTH STIMULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKAPHERESIS; PERIPHERAL BLOOD STEM CELL; REVIEW;

EID: 0033008671     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053470     Document Type: Review

References (42)

1. Epstein RB, Graham TC, Buckner CD, Bryant J, Thomas ED: Allogeneic marrow engraftment by cross circulation in lethally irradiated dogs. Blood 1966;28:692-707.
2. Kessinger A, Smith DM, Strandjord SE, Landmark JD, Dooley DC, Law P, Coccia PF, Warkentin PI, Weisenburger DD, Armitage JO: Allgeneic transplantation of blood-derived, T-cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989;4:643-646.
3. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992;339:640-644.
4. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K: Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996;347:353-357.
5. Dreger P, Suttorp M, Haferlach T, Schroyens W, Löffler H, Schmitz N: Allogeneic G-CSF-mobilised peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993;81:1404-1407.
6. Russell NH, Hunter A, Rogers S, Hanley J, Andersen D: Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993;341:1482.
7. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Löffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (G-CSF). Blood 1995;85:1666-1672.
8. Körbling M, Przepiorka D, Engel H, van Besien K, Giralt S, Andersson B, Huh YO, Kleine HD, Seong D, Deisseroth AB, Champlin RE: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 1995;85:1659-1665.
9. Gratwohl A, Hermans J, Baldomero H: Blood and marrow transplantation in Europe 1995. Bone Marrow Transplant 1997;19:407-419.
10. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner CD: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood 1996;88:2794-2800.
11. Miflin G, Russel NH, Hutchinson RM, Morgan G, Potter M, Pagliuca A, Marsh J, Bell A, Milligan D, Lumley M, Cook, G, Franklin I: Allogeneic peripheral blood stem cell transplantation for haematological malignancies - kinetics of engraftment and GVHD risk. Bone Marrow Transplant 1997;19: 9-13.
12. Przepiorka D, Anderlini P, Ippoliti C, Khouri I, Fietz T, Thall P, Mehra R, Giralt S, Gajewski J, Deisseroth AB, Körbling M: Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplant 1997;19:455-460.
13. Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR, Flowers M, Sullivan KM, Witherspoon RP, Rowley SD, Hansen JA, Storb R, Appelbaum FR: Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997;90:4705-4709.
14. Schmitz N, Bacigalupo A, Hasenclever D, Nagler A, Gluckman E, Clark P, Bourquelot P, Greinix H, Frickhofen N, Ringden O, Zander A, Apperley JF, Gorin C, Borkett K, Schwab G, Goebel M, Russel NH, Gratwohl A: Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998;21:995-1003.
15. Dührsen U, Villeval J-L, Boyd J, Kannourakis G, Morstyn G, Metcalf D: Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988;72:2074-2081.
16. Socinski MA, Elias A, Schnipper L, Cannistra SA, Antman KH, Griffin JD: Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988;ii:1194-1198.
17. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994;87:609-613.
18. Fritsch G, Fischmeister G, Haas OA, Peters C, Gadner H, Strobl H, Höcker P, Kurz M: Peripheral blood hematopoietic progenitor cells of cytokine-stimulated healthy donors as an alternative for allogeneic transplantation. Blood 1994;83:3420-3421.
19. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldham F, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 1995;85:275-282.
20. Hohaus S, Voso MT, Haas R: The Role of cytokines in the mobilization of blood stem cells; in Reiffers J, Goldman J, Armitage JO (eds): Blood Stem Cell Transplantation. London, Martin Dunitz, 1998, pp 37-54.
21. Anderlini P, Korbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, Howe C, Leitman S, Horowitz M, Gluckman E, Champlin R: Allogeneic blood stem cell transplantation: Considerations for donors (e rial) Blood 1997;90:903-908.
22. Suzue T, Kawano Y, Takaue Y, Kuroda Y: Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor. Exp Hematol 1994;22:888-892.
23. Bensinger WI, Buckner CD, Rowley S, Storb R, Appelbaum FR: Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells. Bone Marrow Transplant 1996;17(suppl 2):S19-S21.
24. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D: Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995;86: 4437-4445.
25. Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, McCullough J: Treatment of normal individuals with granulocyte-colony-stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996;36:601-610.
26. Haas R, Ho AD, Bredthauer U, Cayeux S, Egerer G, Knauf W, Hunstein W: Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1990;18: 94-98.
27. Rosenfeld CS, Bolwell B, LeFever A, Taylor R, List A, Fay J, Collins R, Andrews F, Pallansch P, Schuster MW, Resta D, Levitt D, Nemunaitis J: Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF. Bone Marrow Transplant 1996;17:179-183.
28. Laterveer L, Lindley IJD, Heemskerk DPM, Camps JAJ, Pauwels EKJ, Willemze R, Fibbe WE: Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996;87:781-788.
29. Rasko JE, Basser RL, Boyd J, Mansfield R, O'Malley O, Hussein S, Berndt MC, Clarke K, O'Byrne J, Sheridan WP, Grigg AP, Begley C: Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Br J Haematol 1997;97:871-880.
30. Sudo Y, Shimazaki C, Ashihara E, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M: Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilisation of hematopoietic stem cells and progenitor cells into blood in mice. Blood 1997;89: 3186-3191.
31. To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 1997;89:2233-2258.
32. Ho AD, Young D, Maruyama M, Law P, Corringham RET, Mason JR, Oldham F, Mills B, Terstappen L, Lane TA: Mobilization and purification of CD34+ cells from normal donors - Regimens with G-CSF, GM-CSF, or a combination of both. Bone Marrow Transplant 1996;17(suppl 2):S34-S37.
33. Moskowitz CH, Stiff P, Gordon MS, McNiece I, Ho AD, Costa JJ, Broun ER, Bayer RA, Wyres M, Hill J, Gabrilove J: Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients - Results of a phase I/II trial. Blood 1997;89:3136-3147.
34. DeLuca E, Sheridan WP, Watson D, Szer J, Begley CG: Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer 1992;66:893-899.
35. Zeller W, Gutensohn K, Stockschläder M, Dierlamm J, Kröger N, Koehne G, Hummel K, Kabisch H, Weh HJ, Kühnl P, Hossfeld DK, Zander AR: Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. Bone Marrow Transplant 1996;17:709-713.
36. Höglund M, Smedmyr B, Simonsson B, Tötterman T, Bengtsson M: Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 1996;18:19-27.
37. Stroncek DF, Clay ME, Herr G, Smith J, Jaszcz WB, Ilstrup S, McCullough J: The kinetics of Gc-CSF mobilization of CD34+ cells in healthy people. Transfus Med 1997;7:19-24.
38. Watts MJ, Addison I, Ings SJ, Long SG, Hartley S, Warrington S, Boyce M, Linch DC: Optimal timing for collection of PBPC after glycosylated G-CSF administration. Bone Marrow Transplant 1998;21: 365-368.
39. Jones HM, Jones SA, Watts MJ, Khwaja A, Mills W, Fielding A, Goldstone AH, Linch DC: Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol 1994;12:1693-1702.
40. Burger SR, Fautsch SK, Stroncek DF, McCullough J: Concentration of citrate anticoagulant in peripheral blood progenitor cell collections. Transfusion 1996;36:798-801.
41. To LB: Mobilizing and collecting blood stem cells; in Reiffers J, Goldman JM, Armitage JO (eds): Blood Stem Cell Transplantation. London, Martin Dunitz, 1998, pp101-122.
42. Dreger P, Schmitz N: Allogeneic blood stem cell transplantation; in Reiff ers J, Goldman JM, Armitage JO (eds): Blood Stem Cell Transplantation. London, Martin Dunitz, 1998, pp217-231.